合成路线1
该中间体在本合成路线中的序号:
(III) This compound can be obtained by two related ways:
1) The hydrolysis of 3-hydroxy-3-phenyl-1-butyne (I) with aqueous H2SO4 catalyzed by mercuric sulfate gives 3-hydroxy-3-phenyl-2-butanone (II), which is cyclized and decarboxylated by reaction with diethyl oxalate (III) and NaH in hot THF.
2) When the reaction of (II) with (III) is carried out under milder conditions 6-methyl-6-phenyltetrahydropyran-2,3,5-trione (IV) is obtained. This compound is then treated with aqueous NaOH at pH 11.
【1】
Jirkovsky, J.L.; Dvornik, D.; Cayen, M.N.; Process for preparing 4,5-dihydro-4-oxofuran-2-carboxylic acid derivatives. EP 0006305; ES 8100283; US 4169202; WO 8000025 .
|
【2】
Serradell, M.N.; Blancafort, P.; Grau, M.; Castaner, J.; AY-25,712. Drugs Fut 1983, 8, 3, 184.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35961 |
2-phenyl-3-butyn-2-ol
|
127-66-2 |
C10H10O |
详情 | 详情
|
(II) |
35962 |
3-hydroxy-3-phenyl-2-butanone
|
|
C10H12O2 |
详情 |
详情
|
(III) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(IV) |
35963 |
6-methyl-6-phenyl-2H-pyran-2,3,5(4H,6H)-trione
|
|
C12H10O4 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(III) The hydrogenation of 2-hydroxy-3-allyl-6-(2-hydroxypropoxy)acetophenone (I) with H2 over Pd/C in ethanol gives 2-hydroxy-3-propyl-6-(2-hydroxypropoxy)acetophenone (II), which is then cyclized with diethyl oxalate (III) by means of sodium ethoxide in refluxing ethanol. The sodium salt is prepared by treatment of the acid with NaHCO3 in water.
【1】
Cairns, H.; Hazard, R.; King, J.; Lee, T.B.; DE 2530289 .
|
【2】
Sneddon, J.M.; Serradell, M.N.; Castaner, J.; Blancafort, P.; FPL-52,694. Drugs Fut 1982, 7, 6, 388.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37073 |
1-[3-allyl-2-hydroxy-6-(2-hydroxypropoxy)phenyl]-1-ethanone
|
|
C14H18O4 |
详情 |
详情
|
(II) |
37074 |
1-[2-hydroxy-6-(2-hydroxypropoxy)-3-propylphenyl]-1-ethanone
|
|
C14H20O4 |
详情 |
详情
|
(III) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(A) The alkylation of 4-(N-acetyl-N-ethylamino)-2-hydroxyacetophenone (I) with allyl bromide (II) by means of K2CO3 in DMF gives the allyl ether (III), which is isomerized by refluxing in diethylaniline to 4-(N-acetyl-N-ethylamino)-3-allyl-2-hydroxyacetophenone (IV) The reduction of (IV) with H2 over Pd/C in ethanol affords the corresponding propyl derivative (V), which is deacetylated with HBr in refluxing acetic acid water to 4-(ethylamino)-3-propyl-2-hydroxyacetophenone (VI). The addition of (VI) dimethyl acetylenedicarboxylate (VII) in refluxing ethanol affords the aminomaleate (VIII), which by cyclization witn polyphosphoric acid at 100 C gives methyl 1-ethyl-6-acetyl-7-hydroxy-4 oxo-8-propyl-4H-quinoline-2-carboxylate (IX). The condensation of (IX) with diethyl oxalate in DMF by means of NaH results in the ester of the final product (X), which is then hydrolyzed with NaHCO3 iin refluxing ethanol.
【1】
Wilkinson, D.J.; Lockley, W.J.S.; Synthesis of nedocromil sodium labelled with tritium, deuterium and carbon-14. J Label Compd Radiopharm 1985, 22, 9, 883.
|
【2】
Caims, H.; Cox, D. (Rhone-Poulenc Rorer Ltd.); Nouvelles pyranoquinoleinones et leurs compositions pharmaceutiques. DE 2819215; ES 469391; JP 1199909; JP 53137969 .
|
【3】
Cairns, H.; Cox, D. (Rhone-Poulenc Rorer Ltd.); 4,6-Dioxo-4H,6H-pyrano[3,2-g]quinoline-2,8-dicarbocyclic acids. GB 2022078 .
|
【4】
Prous, J.; Castaner, J.; Nedocromil sodium. Drugs Fut 1986, 11, 9, 756.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(I) |
24545 |
N-(4-acetyl-3-hydroxyphenyl)-N-ethylacetamide
|
|
C12H15NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
24547 |
3-[4-acetyl-3-(allyloxy)phenyl]-2-pentanone
|
|
C16H20O3 |
详情 |
详情
|
(IV) |
24548 |
N-(4-acetyl-2-allyl-3-hydroxyphenyl)-N-ethylacetamide
|
69049-64-5 |
C15H19NO3 |
详情 | 详情
|
(V) |
24549 |
N-(4-acetyl-3-hydroxy-2-propylphenyl)-N-ethylacetamide
|
|
C15H21NO3 |
详情 |
详情
|
(VI) |
24550 |
1-[4-(ethylamino)-2-hydroxy-3-propylphenyl]-1-ethanone
|
69049-68-9 |
C13H19NO2 |
详情 | 详情
|
(VII) |
24551 |
Dimethyl acetylenedicarboxylate; Dimethyl 2-butynedioate;Acetylenedicarboxylic acid dimethyl ester |
762-42-5 |
C6H6O4 |
详情 | 详情
|
(VIII) |
24552 |
dimethyl (Z)-2-[4-acetyl(ethyl)-3-hydroxy-2-propylanilino]-2-butenedioate
|
77941-04-9 |
C19H25NO6 |
详情 | 详情
|
(IX) |
24553 |
methyl 6-acetyl-1-ethyl-7-hydroxy-4-oxo-8-propyl-1,4-dihydro-2-quinolinecarboxylate
|
69049-70-3 |
C18H21NO5 |
详情 | 详情
|
(X) |
24554 |
diethyl 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylate
|
69049-72-5 |
C23H25NO7 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(VIII) Treatment of alanine (I) with phosgene in THF provides N-carboxyanhydride derivative (II), which is then coupled to proline (III) by means of KOH and K2CO3 in THF/H2O or acetonitrile to provide dipeptide (IV). Coupling of (IV) to ethyl 2-oxo-4-phenylbutyrate (V) by means of H2 over Raney-Ni in EtOH (or EtOH/HOAc), followed by the corresponding work-up for isomer separation, yields derivative (VI). (In turn, ketoester (V) can be obtained by treatment of 2-phenylethyl bromide (VII) with Mg turnings in refluxing THF, followed by reaction of the resulting Grignard reagent with diethyl oxalate (VIII) in THF). Finally, the desired product is obtained by saponification of the ethyl ester group of (VI) with NaOH.
【1】
Blacklock, T.J.; et al.; Synthesis of semisynthetic dipeptides using N-carboxyanhydrides and chiral induction on Raney nickel. A method practical for large scale. J Org Chem 1988, 53, 4, 836.
|
【2】
Reider, P.J.; Huffman, M.A.; Leblond, C.; Sun, Y. (Merck & Co., Inc.); Improved stereoselective process for enalapril. WO 0017228 .
|
【3】
Blacklock, T.J.; Shuman, R.F. (Merck & Co., Inc.); Process for preparing polypeptides. US 4510083 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50831 |
L-Alanine; L-2-Aminopropionic acid; (S)-(+)-2-Aminopropionic acid; L-2-Aminopropionic acid; (S)-2-Aminopropionic acid; (S)-(+)-Alanine
|
56-41-7 |
C3H7NO2 |
详情 | 详情
|
(II) |
50829 |
(4S)-4-methyl-1,3-oxazolidine-2,5-dione; S-Alanine-N-carboxylic acid anhydride
|
2224-52-4 |
C4H5NO3 |
详情 | 详情
|
(III) |
16731 |
L-proline
|
147-85-3 |
C5H9NO2 |
详情 | 详情
|
(IV) |
32151 |
(2S)-1-[(2S)-2-aminopropanoyl]-2-pyrrolidinecarboxylic acid
|
13485-59-1 |
C8H14N2O3 |
详情 | 详情
|
(V) |
50832 |
ethyl 2-oxo-4-phenylbutanoate
|
|
C12H14O3 |
详情 |
详情
|
(VI) |
50830 |
(2S)-1-((2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl)-2-pyrrolidinecarboxylic acid
|
|
C20H28N2O5 |
详情 |
详情
|
(VII) |
20730 |
1-(2-bromoethyl)benzene;1-Bromo-2-phenylethane;(2-Bromoethyl)benzene;Phenethyl bromide |
103-63-9 |
C8H9Br |
详情 | 详情
|
(VIII) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) 1) The cyclization of 2,3-dimethylaniline (I) with diethyl acetylmalonate (II) in 1-chloronaphthalene at 240 C gives 3-acetyl-4-hydroxy-7,8-dimethylquinolin-2(1H)-one (III), which by reaction with diethyl oxalate (IV) by means of sodium ethoxide in refluxing benzene yields ethyl-4-(4-hydroxy-7,8-dimethyl-2-oxo-1,2-dihydroquinolin-3yl)-2,4-dioxo-butanoate (V). The cyclization of (V) in acetic acid concentrated HCl at 100 C affords 5,6-dihydro-7,8 dimethyl-4,5-dioxo-4H-pyrano[3,2-c]quinoline-2-carboxylic acid (VI), which is converted into the corresponding acyl chloride (VII) by reaction with refluxing SOCl2. Finally, this compound is treated with hot 3-methylbutanol (VIII).
【1】
Takahashi, K.; Hata, S.; Morinaka, Y.; Yamada, S.; Antiallergic agents I. Pyranoquinoline derivatives. Eur J Med Chem - Chim Ther 1981, 16, 3, 251.
|
【2】
Castaner, J.; Prous, J.; Repirinast. Drugs Fut 1987, 12, 1, 37.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23025 |
2,3-Dimethylphenylamine; 2,3-Dimethylaniline; 2,3-Xylidine
|
87-59-2 |
C8H11N |
详情 | 详情
|
(II) |
23026 |
diethyl 2-acetylmalonate
|
570-08-1 |
C9H14O5 |
详情 | 详情
|
(III) |
23027 |
3-acetyl-4-hydroxy-7,8-dimethyl-2(1H)-quinolinone
|
|
C13H13NO3 |
详情 |
详情
|
(IV) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(V) |
23029 |
ethyl 4-(4-hydroxy-7,8-dimethyl-2-oxo-1,2-dihydro-3-quinolinyl)-2,4-dioxobutanoate
|
|
C17H17NO6 |
详情 |
详情
|
(VI) |
24014 |
Phenyllithium
|
591-51-5 |
C6H5Li |
详情 | 详情
|
(VII) |
23031 |
7,8-dimethyl-4,5-dioxo-5,6-dihydro-4H-pyrano[3,2-c]quinoline-2-carbonyl chloride
|
|
C15H10ClNO4 |
详情 |
详情
|
(VIII) |
23032 |
3-methyl-1-butanol
|
123-51-3 |
C5H12O |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The intermediate (racemic)-2-(methoxycarbonylmethyl)-6,6-dimethyltetrahydropyran-2-carboxylic acid (VIII) has been obtained by several related methods:
1. The Grignard condensation of 4-methyl-3-pentenyl bromide (I) with diethyl oxalate (II) in HF gives the 2-oxoheptenoate (III), which is condensed with methyl acetate (IV) by means of LiHMDS in THF to yield 3-(ethoxycarbonyl)-3-hydroxy-7-methyl-6-octenoic acid methyl ester (V). The cyclization of (V) by means of Ts-OH in hot toluene or by means of hot aqueous formic acid affords 2-(methoxycarbonylmethyl)-6,6-dimethyltetrahydropyran-2-carboxylic acid ethyl ester (VI), which is hydrolyzed with KOH in boiling water to provide the corresponding dicarboxylic acid (VII). Finally, this compound is regioselectively monoesterified by means of BF3/MeOH in methanol to furnish the intermediate (racemic)-2-(methoxycarbonylmethyl)-6,6-dimethyltetrahydropyran-2-carboxylic acid (VIII).
2. The reaction of 3-(ethoxycarbonyl)-3-hydroxy-7-methyl-6-octenoic acid methyl ester (V) with HCl in hot methanol gives 3-(ethoxycarbonyl)-3,7-dihydroxy-7-methyloctanoic acid methyl ester (IX), which is then cyclized by means of ZnCl2 in hot dichloroethane to yield the previously described intermediate (VIII).
3. The hydrolysis of 3-(ethoxycarbonyl)-3-hydroxy-7-methyl-6-octenoic acid methyl ester (V) with KOH in refluxing methanol/water gives the corresponding diacid (X), which is regioselectively monoesterified by means of BF3/MeOH in methanol to yield 3-carboxy-3-hydroxy-7-methyl-6-octenoic acid methyl ester (XI). Finally, this compound is cyclized by means of Ts-OH in hot toluene to afford the previously described carboxylic intermediate (VIII).
The racemic acid (VIII) is submitted to optical resolution by esterification with quinine (XII) by means of 2,4,6-trichlorobenzoyl chloride and TEA or DCC to give a diastereomeric mixture of esters (XIII) that is separated by preparative HPLC to obtain the desired diastereomer (XIV). The hydrolysis of (XIV) with KOH in refluxing ethanol/water gives the corresponding chiral dicarboxylic acid (XV), which is regioselectively monoesterified with BF3/MeOH in methanol to yield the chiral (R)-2-(methoxycarbonylmethyl)-6,6-dimethyltetrahydropyran-2-carboxylic acid (XVI). The esterification of (XVI) with cephalotaxine (XVII) by means of 2,4,6-trichlorobenzoyl chloride and TEA in toluene affords the corresponding ester (XVIII), which is treated with HBr in dichloromethane/HOAc, providing the bromoester (XIX). Finally, this compound is treated with NaHCO3, CaCO3 or BaCO3 in acetone/water to give the target hydroxyester.
【1】
Robin, J.-P.; et al.; The first semi-synthesis of enantiopure homoharringtonine via anhydrohomoharringtonine from a preformed chiral acyl moiety. Tetrahedron Lett 1999, 40, 2931.
|
【2】
Robin, J.; Robin, J.-P.; Cavoleau, S.; Chauviat, L.; Charbonnel, S.; Dhal, R.; Dujardin, G.; Fournier, F.; Gilet, C.; Girodier, L.; Mevelec, L.; Poutot, S.; Rouaud, S. (OncoPharm Corp.); Novel cephalotaxane derivs. and process for their preparation. EP 1064285; FR 2776292; WO 9948894 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31462 |
5-bromo-2-methyl-2-pentene
|
|
C6H11Br |
详情 |
详情
|
(II) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
52779 |
ethyl 3,6-dimethyl-2-oxo-5-heptenoate
|
|
C11H18O3 |
详情 |
详情
|
(IV) |
44566 |
methyl acetate
|
79-20-9 |
C3H6O2 |
详情 | 详情
|
(V) |
52780 |
1-ethyl 4-methyl 2-hydroxy-2-(4-methyl-3-pentenyl)succinate
|
|
C13H22O5 |
详情 |
详情
|
(VI) |
52781 |
ethyl 2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylate
|
|
C13H22O5 |
详情 |
详情
|
(VII) |
52782 |
2-(carboxymethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylic acid
|
|
C10H16O5 |
详情 |
详情
|
(VIII) |
52783 |
2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylic acid
|
|
C11H18O5 |
详情 |
详情
|
(IX) |
52784 |
1-ethyl 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate
|
|
C13H24O6 |
详情 |
详情
|
(X) |
52785 |
2-hydroxy-2-(4-methyl-3-pentenyl)succinic acid
|
|
C10H16O5 |
详情 |
详情
|
(XI) |
52786 |
2-hydroxy-2-(2-methoxy-2-oxoethyl)-6-methyl-5-heptenoic acid
|
|
C11H18O5 |
详情 |
详情
|
(XII) |
52787 |
(R)-(6-methoxy-4-quinolinyl)[(2S,4S,5R)-5-vinyl-1-azabicyclo[2.2.2]oct-2-yl]methanol
|
|
C20H24N2O2 |
详情 |
详情
|
(XIII) |
52788 |
(R)-(6-methoxy-4-quinolinyl)[(2S,4S,5R)-5-vinyl-1-azabicyclo[2.2.2]oct-2-yl]methyl 2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylate
|
|
C31H40N2O6 |
详情 |
详情
|
(XIV) |
52789 |
(R)-(6-methoxy-4-quinolinyl)[(2S,4S,5R)-5-vinyl-1-azabicyclo[2.2.2]oct-2-yl]methyl (2R)-2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylate
|
|
C31H40N2O6 |
详情 |
详情
|
(XV) |
52790 |
(2R)-2-(carboxymethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylic acid
|
|
C10H16O5 |
详情 |
详情
|
(XVI) |
52791 |
(2R)-2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylic acid
|
|
C11H18O5 |
详情 |
详情
|
(XVII) |
52792 |
(1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-ol
|
|
C18H21NO4 |
详情 |
详情
|
(XVIII) |
52793 |
(1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-yl (2R)-2-(2-methoxy-2-oxoethyl)-6,6-dimethyltetrahydro-2H-pyran-2-carboxylate
|
|
C29H37NO8 |
详情 |
详情
|
(XIX) |
52794 |
1-[(1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-yl] 4-methyl (2R)-2-(4-bromo-4-methylpentyl)-2-hydroxybutanedioate
|
|
C29H38BrNO8 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(V) The condensation of 2-(2-methyl-3-nitrophenyl)acetic acid (I) with dipropylamine (II) by means of refluxing SOCl2 gives the corresponding amide (III), which is reduced with borane/THF yielding the tertiary amine (IV). The condensation of (IV) with diethyl oxalate by means of sodium ethoxide in refluxing ethanol affords the pyruvate ester (V), which is treated with NaOH and H2O2 yielding the acetic acid derivative (VI). Finally, this compound is cyclyzed by hydrogenation with H2 over Pd/C in ethanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34861 |
2-(2-methyl-3-nitrophenyl)acetic acid
|
|
C9H9NO4 |
详情 |
详情
|
(II) |
21856 |
N,N-dipropylamine; N-propyl-1-propanamine
|
142-84-7 |
C6H15N |
详情 | 详情
|
(III) |
34862 |
2-(2-methyl-3-nitrophenyl)-N,N-dipropylacetamide
|
|
C15H22N2O3 |
详情 |
详情
|
(IV) |
34863 |
N-(2-methyl-3-nitrophenethyl)-N,N-dipropylamine; N-(2-methyl-3-nitrophenethyl)-N-propyl-1-propanamine
|
|
C15H24N2O2 |
详情 |
详情
|
(V) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(VI) |
34864 |
ethyl 3-[2-[2-(dipropylamino)ethyl]-6-nitrophenyl]-2-oxopropanoate
|
|
C19H28N2O5 |
详情 |
详情
|
(VII) |
34865 |
2-[2-[2-(dipropylamino)ethyl]-6-nitrophenyl]acetic acid
|
|
C16H24N2O4 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IV) By condensation of ethyl 8-propyl-7-hydroxy-4-oxo-4H-1-benzopyran-2-carboxylate (I) with 4-(2,3-epoxypropoxy)-3-propyl-2-hydroxyacetophenone (II) by means of benzyltrimethylammonium hydroxide in refluxing DMF, followed by hydrolysis with NaHCO3 in refluxing ethanol - water.
The starting compounds (I) and (II) are prepared as follows:
1) The condensation of 3-propyl-2,4-dihydroxyacetophenone (III) with diethyl oxalate (IV) by means of sodium ethoxide in refluxing ethanol gives (I).
2) The condensation of acetophenone (III) with 1-chloro-2,3-epoxypropane (V) by means of KOH in refluxing ethanol - water gives (II).
【1】
Pratt, A.D.; Bantick, J..; Lee, T.B.; Chamberlain, T.R.; Hardern, D.N.; Appleton, R.A.; Antagonits of slow reacting substance od anaphylaxis. Synthesis of a series of chromone-2-carboxylic acids. J Med Chem 1979, 20, 3, 371.
|
【2】
Augstein, J.; Lee, T.B.; Carter, D. (AstraZeneca plc); Chromone derivs.. FR 2147287 .
|
【3】
Augstein, J.; Carter, D.; Lee, T.B. (AstraZeneca plc); Chrome cpds. having SRS-A properties. US 3882148 .
|
【4】
Blancafort, P.; Castaner, J.; Sneddon, J.M.; Serradell, M.N.; FPL-55,712. Drugs Fut 1982, 7, 7, 472.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
37126 |
|
|
C10H18NO |
详情 |
详情
|
(I) |
37124 |
ethyl 7-hydroxy-4-oxo-8-propyl-4H-chromene-2-carboxylate
|
|
C15H16O5 |
详情 |
详情
|
(II) |
37125 |
1-[2-hydroxy-4-(2-oxiranylmethoxy)-3-propylphenyl]-1-ethanone
|
|
C14H18O4 |
详情 |
详情
|
(III) |
13137 |
2',4'-Dihydroxy-3'-propylacetophenone; 1-(2,4-Dihydroxy-3-propylphenyl)-1-ethanone
|
40786-69-4 |
C11H14O3 |
详情 | 详情
|
(IV) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(V) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(VI) Condensation of 2-bromo-p-toluidine (I) with cyclohexane-1,3-dione (II) gives bromo enaminone (III), which is N-methylated with iodomethane and NaH, affording tertiary enaminone (IV). Treatment of (IV) with triphenylphosphine-palladium acetate complex/NHCO3 or palladium acetate in acetonitrile provides carbazolone (V). Treatment of carbazolone (V) with sodium metal in EtOH/dioxane (or sodium methoxide in 1,2-dimethoxyethane) and diethyl oxalate (VI) provides ethoxallyl derivative (VII), which is then converted into glyoxylic acid lactone (VIII). Coupling of (VIII) with 2-methylimidazol (IX) by means of benzyltriethylammonium chloride in CHCl3/H2O furnishes glyoxylate (X), which is converted into the target product by reaction again with 2-methylimidazol (IX) in dioxane and final treatment with HCl. Alternatively, glyoxylate (X) can be directly obtained from (VIII) by reaction with formaldehyde and 2-methylimidazol (IX) in dioxane.
【1】
Iida, H.; et al.; Intramolecular cyclization of enaminones involving arylpalladium complexes. Synthesis of carbazoles. J Org Chem 1980, 45, 15, 2938.
|
【2】
Harsanyi, K.; Bod, P.; Trischler, F.; Fekecs, E.; Horvath, E.; Csehl, A.; Hegedus, B.; Mersich, E.; Szabo, G. (Gedeon Richter Ltd.); Carbazolone derivs. and process for preparing the same. EP 0595111 .
|
【3】
Dobay, L.; Czibula, L.; Szantay, C.; Gazdag, M.; Greiner, I.; Werkne Papp, E.; Tarkanyi, G.; Zsoldosne Babjak, M.; Mihalyfi, K. (Gedeon Richter Ltd.); An intermediate and process for its synthesis. WO 0172716 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27739 |
2-bromoaniline
|
615-36-1 |
C6H6BrN |
详情 | 详情
|
(II) |
11244 |
1,3-Cyclohexanedione
|
504-02-9 |
C6H8O2 |
详情 | 详情
|
(III) |
53887 |
3-(2-bromoanilino)-2-cyclohexen-1-one
|
n/a |
C12H12BrNO |
详情 | 详情
|
(IV) |
53888 |
3-[2-bromo(methyl)anilino]-2-cyclohexen-1-one
|
n/a |
C13H14BrNO |
详情 | 详情
|
(V) |
53889 |
9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one
|
27387-31-1 |
C13H13NO |
详情 | 详情
|
(VI) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(VII) |
53890 |
ethyl 2-hydroxy-2-(9-methyl-4-oxo-1,2,4,9-tetrahydro-3H-carbazol-3-ylidene)acetate
|
n/a |
C17H17NO4 |
详情 | 详情
|
(VIII) |
53891 |
|
n/a |
C16H13NO4 |
详情 | 详情
|
(IX) |
15670 |
2-Methylimidazole; 2-Methyl-1H-imidazole
|
693-98-1 |
C4H6N2 |
详情 | 详情
|
(X) |
53892 |
2-methyl-1H-imidazol-3-ium 2-[3-(hydroxymethyl)-9-methyl-4-oxo-2,3,4,9-tetrahydro-1H-carbazol-3-yl]-2-oxoacetate
|
n/a |
C20H21N3O5 |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) The condensation of 2',6'-dimethoxyacetophenone (I) with diethyl oxalate (II) by means of sodium methoxide in refluxing methanol gives the dioxobutyrate (III), which is cyclized with 7-chloroquinoline-4-hydrazine (IV) in refluxing acetic acid yielding the pyrazole derivative (V). The hydrolysis of the ester group of (V) with KOH in refluxing methanol/water affords the corresponding carboxylic acid (VI), which is finally treated with SOCl2 in refluxing toluene and condensed with 2-aminoadamantane-2-carboxylic acid.
【1】
Boigegrain, R.; Gully, D.; Jeanjean, F.; Molimard, J.-C. (Sanofi-Synthélabo ); Amido-3-pyrazole derivs., process for their preparation and pharmaceutical compsns. containing them. EP 0477049; FR 2665898; JP 1992244065; US 5420141; US 5607958; US 5616592; US 5635526; US 5744491; US 5744493 . |
【2】
Maffrand, J.P.; Gully, D.; Boigegrain, R.; Soubrie, P.; Kitabgi, P.; Rostene, W.; Le Fur, G.; Neurotensin receptor agonists and antagonists. Drugs Fut 1993, 18, 12, 1137.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
41280 |
2-amino-2-adamantanecarboxylic acid
|
|
C11H17NO2 |
详情 |
详情
|
(I) |
41275 |
1-(2,6-dimethoxyphenyl)-1-ethanone
|
2040-04-2 |
C10H12O3 |
详情 | 详情
|
(II) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
41276 |
sodium (Z)-4-(2,6-dimethoxyphenyl)-1-methoxy-1,4-dioxo-2-buten-2-olate
|
|
C13H13NaO6 |
详情 |
详情
|
(IV) |
41277 |
7-chloro-4-hydrazinoquinoline
|
23834-14-2 |
C9H8ClN3 |
详情 | 详情
|
(V) |
41278 |
methyl 1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxylate
|
|
C22H18ClN3O4 |
详情 |
详情
|
(VI) |
41279 |
1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxylic acid
|
|
C21H16ClN3O4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(III) Reaction of tetrabutylammonium [11C]cyanide (I) with methyl chloroformate in a two phase system afforded labeled methyl cyanoformate (II), which was refluxed in ethanolic HCl to yield diethyl [1-11C]oxalate (III).
【1】
Thorell, J.O.; et al.; Synthesis of a C-11-labelled nitrated 1,4-dihydroquinoxaline-2,3-dione, the NMDA glycine receptor antagonist ACEA 1021 (Licostinel). J Label Compd Radiopharm 1998, 41, 4, 345-353.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16993 |
methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate |
79-22-1 |
C2H3ClO2 |
详情 | 详情
|
(II) |
18001 |
methyl 2-nitriloacetate; carbonocyanic acid, methyl ester
|
17640-15-2 |
C3H3NO2 |
详情 | 详情
|
(II) |
45300 |
methyl 2-nitriloacetate
|
|
C3H3NO2 |
详情 |
详情
|
(III) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
45301 |
ethyl 2-ethoxy-2-oxoacetate
|
|
C6H10O4 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(III) Phenylenediamine (IV) was protected as the benzoselenadiazole (V) on treatment with selenium dioxide in 1 N HCl. The subsequent nitration with nitric and sulfuric acid provided (VI), which on stirring with a mixture of concentrated HCl and HI gave the nitrodiamine (VII). Cyclization of (VII) with labeled diethyl oxalate (III) in sulfuric acid at 175 C yielded labeled quinoxalinedione.
【1】
Thorell, J.O.; et al.; Synthesis of a C-11-labelled nitrated 1,4-dihydroquinoxaline-2,3-dione, the NMDA glycine receptor antagonist ACEA 1021 (Licostinel). J Label Compd Radiopharm 1998, 41, 4, 345-353.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
45301 |
ethyl 2-ethoxy-2-oxoacetate
|
|
C6H10O4 |
详情 |
详情
|
(IV) |
18003 |
4,5-dichloro-1,2-benzenediamine; 4,5-Dichloro-o-phenylenediamine; 2-amino-4,5-dichlorophenylamine
|
5348-42-5 |
C6H6Cl2N2 |
详情 | 详情
|
(V) |
18004 |
5,6-dichloro-2,1,3-benzoselenadiazole
|
|
C6H2Cl2N2Se |
详情 |
详情
|
(VI) |
18005 |
5,6-dichloro-4-nitro-2,1,3-benzoselenadiazole
|
|
C6HCl2N3O2Se |
详情 |
详情
|
(VII) |
18006 |
2-amino-4,5-dichloro-3-nitrophenylamine; 4,5-dichloro-3-nitro-1,2-benzenediamine
|
|
C6H5Cl2N3O2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(III) Alternatively, condensation of phenylenediamine (IV) with oxalate (III) in hot sulfuric acid afforded labeled quinoxalinedione (VIII), to which was added acetic acid or diethyl oxalate in order to protect amino groups, and was then nitrated with fuming nitric acid and sulfuric acid.
【1】
Thorell, J.O.; et al.; Synthesis of a C-11-labelled nitrated 1,4-dihydroquinoxaline-2,3-dione, the NMDA glycine receptor antagonist ACEA 1021 (Licostinel). J Label Compd Radiopharm 1998, 41, 4, 345-353.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
45301 |
ethyl 2-ethoxy-2-oxoacetate
|
|
C6H10O4 |
详情 |
详情
|
(IV) |
18003 |
4,5-dichloro-1,2-benzenediamine; 4,5-Dichloro-o-phenylenediamine; 2-amino-4,5-dichlorophenylamine
|
5348-42-5 |
C6H6Cl2N2 |
详情 | 详情
|
(VIII) |
18007 |
6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione
|
25983-13-5 |
C8H4Cl2N2O2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(VII) A new synthesis of ML-3000 has been published:
The reaction of 3-phenyl-2-propynyl chloride (I) with isobutyraldehyde (II) by means of tetrabutylammonium iodide/NaI/NaOH in toluene/water gives 2,2-dimethyl-5-phenyl-4-pentynal (III), which is condensed with glycine methyl ester by means of NaBH(OAc)3 and triethylamine in dichloromethane yielding the N-alkyl-glycine (V). The cyclization of (V) by means of pivalic acid at 150 C affords the bicyclic ketone (VI), which is condensed with diethyl oxalate (VII) by means of sodium ethoxide in ethanol giving the ethoxalyl derivative (VIII). The esterification of (VIII) with the triflic amide (IX) yields the triflate (X), which is condensed with 4-chlorophenylboronic acid (XI) by means of palladium tetrakis(triphenylphosphine) as catalyst in refluxing THF affording the compound (XII). The reduction of the oxoacetic group with tosyl hydrazide (XIII) in refluxing ethanol gives the expected acetate derivative (XIV), which is finally hydrolyzed with NaOH in hot ethanol/water.
【1】
Cossy, J.; Belotti, D.; Synthesis of ML-3000, an inhibitor of cyclooxygenase and 5-lipoxygenase. J Org Chem 1997, 62, 23, 7900.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17565 |
1-(3-chloro-1-propynyl)benzene
|
|
C9H7Cl |
详情 |
详情
|
(II) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(III) |
17567 |
2,2-dimethyl-5-phenyl-4-pentynal
|
|
C13H14O |
详情 |
详情
|
(IV) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(V) |
17569 |
methyl 2-[(2,2-dimethyl-5-phenyl-4-pentynyl)amino]acetate
|
|
C16H21NO2 |
详情 |
详情
|
(VI) |
17570 |
2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-6(5H)-one
|
|
C15H17NO |
详情 |
详情
|
(VII) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(VIII) |
17572 |
ethyl 2-(6-hydroxy-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl)-2-oxoacetate
|
|
C19H21NO4 |
详情 |
详情
|
(IX) |
17573 |
N-Phenyltrifluoromethanesulfonimide; Trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]methanesulfonamide
|
37595-74-7 |
C8H5F6NO4S2 |
详情 | 详情
|
(X) |
17574 |
ethyl 2-(2,2-dimethyl-7-phenyl-6-[[(trifluoromethyl)sulfonyl]oxy]-2,3-dihydro-1H-pyrrolizin-5-yl)-2-oxoacetate
|
|
C20H20F3NO6S |
详情 |
详情
|
(XI) |
17575 |
4-chlorophenylboronic acid
|
1679-18-1 |
C6H6BClO2 |
详情 | 详情
|
(XII) |
17576 |
ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]-2-oxoacetate
|
|
C25H24ClNO3 |
详情 |
详情
|
(XIII) |
17577 |
p-Toluenesulfonyl Hydrazide; 4-methylbenzenesulfonohydrazide
|
1576-35-8 |
C7H10N2O2S |
详情 | 详情
|
(XIV) |
16723 |
ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetate
|
|
C25H26ClNO2 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(IV) The reaction of ethyl 2-sulfanylacetate (I) with 2-bromoacetonitrile (II) by means of NaOEt in ethanol gives ethyl 2-(cyanomethylsulfanyl)acetate (III), which is cyclized with diethyl oxalate (IV) by means of NaOEt in ethanol yielding 5-cyano-3,4-dihydroxythiophene-2-carboxylic acid ethyl ester (V). The protection of the hydroxyl groups of (V) with 2-methoxyethoxymethyl chloride (Mem-Cl) and DIEA in dichloromethane affords the protected thiophene (VI), which is reduced with (t-BuO)2AlH in THF providing the carbinol (VII). The oxidation of (VII) with MnO2 in dichloromethane yields the carbaldehyde (VIII), which is condensed with malonodinitrile (IX) by means of piperidine in dioxane giving the alkylidenemalonodinitrile (X). The epoxidation of (X) with tert-butyl hydroperoxide and TEA in dioxane yields the epoxide (XI), which is treated with HCl in THF to afford 2-chloro-2-[5-cyano-3,4-bis(2-methoxyethoxymethoxy) thiophen-2-yl]acetic acid (XII). The esterification of (XII) with diphenyldiazomethane affords the corresponding diphenylmethyl ester (XIII), which is condensed with N-hydroxyphthalimide (XIV) and NaHCO3 in dichloromethane providing the adduct (XV). The cleavage of the phthalimido group of (XV) with hydrazine in methanol gives 2-(aminooxy)-2-[5-cyano-3,4-bis(2-methoxyethoxymethoxy)thiophen-2-yl]acetic acid diphenylmethyl ester (XVI), which is condensed with 2-oxo-2-[2-(tritylamino)thiazol-4-yl]acetic acid (XVII) yielding the corresponding alcoxyimino derivative (XVIII).
【1】
Aszodi, J.; Dini, C.; Fauveau, P. (Aventis Pharma SA); Cephalosporins having in position 7 as substd. axymino radical, intermediates, processes for their preparation and their use as medicaments. CA 2111164; EP 0628562; JP 1994345776 .
|
【2】
Dini, C.; Aszodi, J.; Synthesis of a dihydroxythiophene analogue of catechosporines. Bioorg Med Chem Lett 2000, 10, 4, 349.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
23995 |
ethyl 2-sulfanylacetate
|
2713-34-0 |
C4H8O2S |
详情 | 详情
|
(II) |
31883 |
2-bromoacetonitrile
|
590-17-0 |
C2H2BrN |
详情 | 详情
|
(III) |
35506 |
ethyl 2-[(cyanomethyl)sulfanyl]acetate
|
|
C6H9NO2S |
详情 |
详情
|
(IV) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(V) |
35507 |
ethyl 5-cyano-3,4-dihydroxy-2-thiophenecarboxylate
|
|
C8H7NO4S |
详情 |
详情
|
(VI) |
35508 |
ethyl 5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thiophenecarboxylate
|
|
C16H23NO8S |
详情 |
详情
|
(VII) |
35509 |
5-(hydroxymethyl)-3,4-bis[(2-methoxyethoxy)methoxy]-2-thiophenecarbonitrile
|
|
C14H21NO7S |
详情 |
详情
|
(VIII) |
35510 |
5-formyl-3,4-bis[(2-methoxyethoxy)methoxy]-2-thiophenecarbonitrile
|
|
C14H19NO7S |
详情 |
详情
|
(X) |
35511 |
2-([5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]methylene)malononitrile
|
|
C17H19N3O6S |
详情 |
详情
|
(XI) |
35512 |
3-[5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]-2,2-oxiranedicarbonitrile
|
|
C17H19N3O7S |
详情 |
详情
|
(XII) |
35513 |
2-chloro-2-[5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]acetic acid
|
|
C15H20ClNO8S |
详情 |
详情
|
(XIII) |
35514 |
benzhydryl 2-chloro-2-[5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]acetate
|
|
C28H30ClNO8S |
详情 |
详情
|
(XIV) |
13505 |
N-Hydroxyphthalimide; 2-Hydroxy-1H-isoindole-1,3(2H)-dione
|
524-38-9 |
C8H5NO3 |
详情 | 详情
|
(XV) |
35515 |
benzhydryl 2-[5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)oxy]acetate
|
|
C36H34N2O11S |
详情 |
详情
|
(XVI) |
35516 |
benzhydryl 2-(aminooxy)-2-[5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]acetate
|
|
C28H32N2O9S |
详情 |
详情
|
(XVII) |
23008 |
2-oxo-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetic acid
|
|
C24H18N2O3S |
详情 |
详情
|
(XVIII) |
35517 |
2-[(2-(benzhydryloxy)-1-[5-cyano-3,4-bis[(2-methoxyethoxy)methoxy]-2-thienyl]-2-oxoethoxy)imino]-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetic acid
|
|
C52H48N4O11S2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(V) The reaction of tetrahydrofuran (I) with HBr gives 4-bromobutanol (II), which is oxidized with NaOCl and TEMPO to yield the aldehyde (III). The reaction of (III) with ethyleneglycol and Ts-OH provides the cyclic ketal (IV), which is submitted to a Grignard condensation with diethyl oxalate (V) and Mg to give the alpha-ketoester (VI). The hydrolysis of (VI) with LiOH yields the corresponding alpha-ketoacid (VII), which is submitted to a stereoselective amination with ammonia and phenylalanine dehydrogenase to afford 2(S)-amino-5-(1,3-dioxol-2-yl)pentanoic acid (VIII). The reaction of (VIII) with SOCl2 and Me-OH provides 2(S)-amino-5,5-dimethoxypentanoic acid methyl ester (IX). The reaction of L- homocystine (X) with Boc2O gives the N-protected-L-homocystine (XI), which is condensed with pentanoic ester (IX) to yield the dimeric adduct (XII). The cleavage of (XII) with dithiothreitol (DTT) affords the monomeric intermediate (XIII), which is finally cyclized by means of Ms-OH to provide the target pyrido[2,1-b][1,3]thiazepine intermediate (XIV).
【1】
Patel, R.N.; Enzymatic synthesis of chiral intermediates for omapatrilat, an antihypertensive drug. Biomol Eng 2001, 17, 6, 167.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41419 |
tetrahydrofuran
|
109-99-9 |
C4H8O |
详情 | 详情
|
(II) |
50608 |
Tetramethylene Bromohydrin; 4-Bromo-1-butanol;4-bromobutan-1-ol |
33036-62-3 |
C4H9BrO |
详情 | 详情
|
(III) |
50609 |
4-bromobutanal
|
|
C4H7BrO |
详情 |
详情
|
(IV) |
50610 |
2-(3-bromopropyl)-1,3-dioxolane
|
|
C6H11BrO2 |
详情 |
详情
|
(V) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(VI) |
50611 |
ethyl 5-(1,3-dioxolan-2-yl)-2-oxopentanoate
|
|
C10H16O5 |
详情 |
详情
|
(VII) |
50612 |
5-(1,3-dioxolan-2-yl)-2-oxopentanoic acid
|
|
C8H12O5 |
详情 |
详情
|
(VIII) |
50613 |
(2S)-2-amino-5-(1,3-dioxolan-2-yl)pentanoic acid
|
|
C8H15NO4 |
详情 |
详情
|
(IX) |
22504 |
methyl (2S)-2-amino-6,6-dimethoxyhexanoate
|
|
C9H19NO4 |
详情 |
详情
|
(X) |
42169 |
(2S)-2-amino-4-[[(3S)-3-amino-3-carboxypropyl]disulfanyl]butyric acid
|
|
C8H16N2O4S2 |
详情 |
详情
|
(XI) |
50614 |
(2S)-2-[[(benzyloxy)carbonyl]amino]-4-[((3S)-3-[[(benzyloxy)carbonyl]amino]-3-carboxypropyl)disulfanyl]butyric acid
|
|
C24H28N2O8S2 |
详情 |
详情
|
(XII) |
50615 |
dimethyl (7S,10S,17S,20S)-10,17-bis[[(benzyloxy)carbonyl]amino]-3,24-dimethoxy-9,18-dioxo-2,25-dioxa-13,14-dithia-8,19-diazahexacosane-7,20-dicarboxylate
|
|
C42H62N4O14S2 |
详情 |
详情
|
(XIII) |
50616 |
methyl (2S)-2-[((2S)-2-[[(benzyloxy)carbonyl]amino]-4-sulfanylbutanoyl)amino]-6,6-dimethoxyhexanoate
|
|
C21H32N2O7S |
详情 |
详情
|
(XIV) |
50617 |
(4S,7S,10aS)-4-[[(benzyloxy)carbonyl]amino]-5-oxooctahydro-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid
|
|
C18H22N2O5S |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(A) Treatment of carboxylic acid (I) with MeOH and H2SO4 yields methyl ester (II), which is then converted into cyano derivative (III) by reaction with LiCN in DMF and AcOH. Hydrolysis of (III) with aqueous KOH in EtOH provides dicarboxylic acid (IV), which is cyclized by means of Ac2O to give the dicarboxylic anhydride (V).
Alternatively, (V) can be obtained by condensation of ester (VI) with diethyl oxalate (A) in Et2O in the presence of t-BuOK to afford (VII), which is cyclized with H2SO4 and submitted to catalytic hydrogenation over Pd/C.
Condensation of anhydride (V) with (S)-alpha-methylbenzylamine yields a mixture of imides, from which (3aR,9bR)-(IX) is obtained by crystallization. Reduction of (3aR,9bR)-(IX) with BH3·THF followed by hydrogenation over Pd/C affords isoindole derivative (X), which is then alkylated with chloroacetonitrile (XI) in acetonitrile in the presence of DIEA and reduced with LiAlH4 to give the primary amine (XII).
Treatment of (XIII) with POCl3 and Et3N yields 2-chloro-3-cyanopyrazine (XIV), which is oxidized to provide (XV) by means of K2S2O8 in H2SO4. Treatment of N-oxide (XV) with ethyl thioglycolate (XVI) and NaOEt in DMF affords pyrazinothiophene (XVII), which is then chlorinated with POCl3 to give (XVIII). Finally, reaction of amine (XII) with (XVIII) and triphosgene in toluene and Et3N affords the desired product.
【1】
Meyer, M.D.; Altenbach, R.J.; Basha, F.Z.; Carroll, W.A.; Drizin, I.; Kerwin, J.F. Jr.; Lebold, S.A.; Lee, E.L.; Elmore, S.W.; Sippy, K.B.; Tietje, K.R.; Wendt, M.D.; Yamamoto, D.M. (Abbott Laboratories Inc.); Tricyclic substd. hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists. EP 0808318; US 5597823; WO 9622992 . |
【2】
Basha, F.Z.; Meyer, M.D.; Altenbach, R.J.; et al.; Structure-activity studies for a novel series of tricycic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of bening prostatic hyperplasia (BPH). J Med Chem 2000, 43, 8, 1586. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(I) |
42524 |
5-methoxy-3,4-dihydro-1-naphthalenecarboxylic acid
|
|
C12H12O3 |
详情 |
详情
|
(II) |
42525 |
methyl 5-methoxy-3,4-dihydro-1-naphthalenecarboxylate
|
|
C13H14O3 |
详情 |
详情
|
(III) |
42526 |
methyl 2-cyano-5-methoxy-1,2,3,4-tetrahydro-1-naphthalenecarboxylate
|
|
C14H15NO3 |
详情 |
详情
|
(IV) |
42527 |
5-methoxy-1,2,3,4-tetrahydro-1,2-naphthalenedicarboxylic acid
|
|
C13H14O5 |
详情 |
详情
|
(V) |
42528 |
(3aR,9bR)-6-methoxy-3a,4,5,9b-tetrahydronaphtho[1,2-c]furan-1,3-dione
|
|
C13H12O4 |
详情 |
详情
|
(VI) |
42529 |
ethyl 4-(2-methoxyphenyl)butanoate
|
|
C13H18O3 |
详情 |
详情
|
(VII) |
42530 |
diethyl 2-(2-methoxyphenethyl)-3-oxosuccinate
|
|
C17H22O6 |
详情 |
详情
|
(VIII) |
20042 |
(1S)-1-phenyl-1-ethanamine; (1S)-1-phenylethylamine
|
|
C8H11N |
详情 |
详情
|
(IX) |
42531 |
(3aR,9bR)-6-methoxy-2-[(1S)-1-phenylethyl]-3a,4,5,9b-tetrahydro-1H-benzo[e]isoindole-1,3(2H)-dione
|
|
C21H21NO3 |
详情 |
详情
|
(X) |
42532 |
(3aR,9bR)-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]isoindol-6-yl methyl ether; (3aR,9bR)-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]isoindole
|
|
C13H17NO |
详情 |
详情
|
(XI) |
14443 |
2-chloroacetonitrile; chloroacetonitrile
|
107-14-2 |
C2H2ClN |
详情 | 详情
|
(XII) |
42533 |
(3aR,9bR)-2-(2-aminoethyl)-6-methoxy-3a,4,5,9b-tetrahydro-1H-benzo[e]isoindole-1,3(2H)-dione
|
|
C15H18N2O3 |
详情 |
详情
|
(XIII) |
42534 |
3-hydroxy-2-pyrazinecarboxamide
|
55321-99-8 |
C5H5N3O2 |
详情 | 详情
|
(XIV) |
42535 |
3-chloro-2-pyrazinecarbonitrile
|
55557-52-3 |
C5H2ClN3 |
详情 | 详情
|
(XV) |
42536 |
3-chloro-2-cyanopyrazin-1-ium-1-olate
|
|
C5H2ClN3O |
详情 |
详情
|
(XVI) |
23995 |
ethyl 2-sulfanylacetate
|
2713-34-0 |
C4H8O2S |
详情 | 详情
|
(XVII) |
42537 |
7-amino-6-(ethoxycarbonyl)thieno[2,3-b]pyrazin-1-ium-1-olate
|
|
C9H9N3O3S |
详情 |
详情
|
(XVIII) |
42538 |
ethyl 7-amino-2-chlorothieno[2,3-b]pyrazine-6-carboxylate
|
|
C9H8ClN3O2S |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(III) The reaction of 3-(trifluoromethyl)aniline (I) with Boc2O gives the carbamate (II), which is condensed with 14C labeled diethyl oxalate (III) by means of BuLi to yield the ketoester (IV). The cyclization of (IV) by means of refluxing aq. HCl affords the labeled 6-(trifluoromethyl)isatin (V), which is condensed with 5-chloro-2-methoxyphenylmagnesium bromide (VI) to provide the hydroxyketone (VII). The fluorination of (VII) with DAST gives the target compound as a racemic mixture (VIII), which is finally submitted to optical resolution by chiral HPLC.
【1】
Dischino, D.D.; Gribkoff, V.K.; Hewawasam, P.; Luke, G.M.; Rinehart, J.K.; Spears, T.L.; Starrett, J.E. Jr.; Synthesis of 3H and 14C labeled (S)-3-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one, MaxiPost(TM). An agent for post-stroke neuroprotection. J Label Compd Radiopharm 2003, 46, 2, 139. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26347 |
3-(trifluoromethyl)phenylamine; 3-(trifluoromethyl)aniline; 3-aminobenzotrifluoride
|
98-16-8 |
C7H6F3N |
详情 | 详情
|
(II) |
39335 |
tert-butyl 3-(trifluoromethyl)phenylcarbamate
|
|
C12H14F3NO2 |
详情 |
详情
|
(III) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
64193 |
allyl (2R,3S,4R,5R)-2-[({(2R,3R,4R,5S,6R)-5-{[bis(allyloxy)phosphoryl]oxy}-4-{[(3R)-3-methoxydecyl]oxy}-6-(methoxymethyl)-3-[(Z)-11-octadecenoylamino]tetrahydro-2H-pyran-2-yl}oxy)methyl]-6-{[tert-butyl(dimethyl)silyl]oxy}-4-(decyloxy)-5-[(3-oxotetradecanoyl)amino]tetrahydro-2H-pyran-3-yl carbonate |
|
C82H151N2O18PSi |
详情 |
详情
|
(IV) |
39336 |
ethyl 2-[2-[(tert-butoxycarbonyl)amino]-4-(trifluoromethyl)phenyl]-2-oxoacetate
|
|
C16H18F3NO5 |
详情 |
详情
|
(IV) |
64197 |
ethyl 2-[2-[(tert-butoxycarbonyl)amino]-4-(trifluoromethyl)phenyl]-2-oxoacetate
|
|
C16H18F3NO5 |
详情 |
详情
|
(V) |
39337 |
6-(trifluoromethyl)-1H-indole-2,3-dione
|
|
C9H4F3NO2 |
详情 |
详情
|
(V) |
64198 |
6-(trifluoromethyl)-1H-indole-2,3-dione
|
|
C9H4F3NO2 |
详情 |
详情
|
(VI) |
39338 |
bromo(5-chloro-2-methoxyphenyl)magnesium
|
|
C7H6BrClMgO |
详情 |
详情
|
(VII) |
39339 |
3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one
|
|
C16H11ClF3NO3 |
详情 |
详情
|
(VII) |
64199 |
3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one
|
|
C16H11ClF3NO3 |
详情 |
详情
|
(VIII) |
43889 |
3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one
|
|
C16H10ClF4NO2 |
详情 |
详情
|
(VIII) |
64200 |
3-(5-Chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-2,3-dihydro-1H-indol-2-one |
|
C16H10ClF4NO2 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(B) The condensation of 6-acetyl-7-hydroxy-1,2,3,4-tetrahydronaphthalene (I) with allyl bromide (A) by means of K2CO3 in DMF gives 6-acetyl-7-allyloxy-1,2,3,4-tetrahydronaphthalene (II), which is isomerized to 5-allyl-7-acetyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene (III) by heating at 200 C. Hydrogenation of (III) with H2 over Pd/C in ethanol affords 5-propyl-7-acetyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene (IV), which is then cyclized with diethyl oxalate (B) by means of sodium ethoxide in refluxing etha-nol to yield ethyl 10-propyl-4-oxo-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylate (V) [an alternative way to prepare (V) is the cyclization of (III) with diethyl oxalate (B) by means of sodium ethoxide to give ethyl 10-allyl-4-oxo-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylate (VI), which is then reduced to (V) with H2 over Pd/C in ethanol]. The nitration of (V) with nitric acid in sulfuric acid gives ethyl 10-propyl-4-oxo-5-nitro-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylate (VII), which is reduced with H2 over Pd/C in ethanol-acetic acid to afford the corresponding amino derivative (VIII). Finally, this compound is diazotated with NaNO2 and H2SO4 and then treated with 50% H2SO4 at 120 C.
【1】
Brown, R.C.; et al.; DE 2553688 .
|
【2】
BE 0836121 .
|
【3】
Castañer, J.; Blancafort, P.; Hillier, K.; Serradell, M.N.; Proxicromil. Drugs Fut 1979, 4, 12, 889.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(B) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(I) |
39625 |
1-(3-hydroxy-5,6,7,8-tetrahydro-2-naphthalenyl)-1-ethanone
|
|
C12H14O2 |
详情 |
详情
|
(II) |
39626 |
1-[3-(allyloxy)-5,6,7,8-tetrahydro-2-naphthalenyl]-1-ethanone
|
|
C15H18O2 |
详情 |
详情
|
(III) |
39627 |
1-(4-allyl-3-hydroxy-5,6,7,8-tetrahydro-2-naphthalenyl)-1-ethanone
|
|
C15H18O2 |
详情 |
详情
|
(IV) |
39628 |
1-(3-hydroxy-4-propyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-ethanone
|
|
C15H20O2 |
详情 |
详情
|
(V) |
39629 |
ethyl 4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H22O4 |
详情 |
详情
|
(VI) |
39630 |
ethyl 10-allyl-4-oxo-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H20O4 |
详情 |
详情
|
(VII) |
39631 |
ethyl 5-nitro-4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H21NO6 |
详情 |
详情
|
(VIII) |
39632 |
ethyl 5-amino-4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H23NO4 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(II) The condensation of 4,5-dichloro-1,2-phenylenediamine (I) with diethyl oxalate (II) produced quinoxalinedione (III), which was brominated with PBr5 at 155 C to afford the dibromo derivative (IV). Displacement of one bromine group of (IV) with 4-(diethylamino)butylamine (V) furnished (VI). The remaining bromine of (VI) was then displaced with 5-(tributylstannyl)-2,2'-bithienyl (VII) to produce the title compound, isolated as the corresponding hydrochloride salt.
【1】
Li, J.J.; Yue, W.-S.; Trivedi, B.K.; et al.; Structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as potent, non-peptide interleukine-8-receptor antagonists. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 144.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18003 |
4,5-dichloro-1,2-benzenediamine; 4,5-Dichloro-o-phenylenediamine; 2-amino-4,5-dichlorophenylamine
|
5348-42-5 |
C6H6Cl2N2 |
详情 | 详情
|
(II) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
18007 |
6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione
|
25983-13-5 |
C8H4Cl2N2O2 |
详情 | 详情
|
(IV) |
44243 |
2,3-dibromo-6,7-dichloroquinoxaline
|
|
C8H2Br2Cl2N2 |
详情 |
详情
|
(V) |
44244 |
N-(4-aminobutyl)-N,N-diethylamine; N(1),N(1)-diethyl-1,4-butanediamine
|
|
C8H20N2 |
详情 |
详情
|
(VI) |
44245 |
N-(3-bromo-6,7-dichloro-2-quinoxalinyl)-N-[4-(diethylamino)butyl]amine; N(1)-(3-bromo-6,7-dichloro-2-quinoxalinyl)-N(4),N(4)-diethyl-1,4-butanediamine
|
|
C16H21BrCl2N4 |
详情 |
详情
|
(VII) |
44246 |
|
|
C20H32S2Sn |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(I) The cyclization of diethyl oxalate (I) with N-ethylethylenediamine (II) in ethanol gives ethyl-2,3-dioxopiperazine (III), which by reaction first with trimethylsilyl chloride and triethytamine and then with phosgene in THF is converted into 4-ethyl-2,3-dioxopiperazine-1-carboxylic acid chloride (IV). Finally, this compound is condensed with 6-D-(-)-alpha-aminophenylacetamidopenicillanic acid (V) by means of triethylamine in THF - water.
【1】
Saikawa, I.; et al.; Penicillins and cephalosporins and process for producing the same. DE 2519400; FR 2269937; FR 2320295; GB 1508062 .
|
【2】
Loren, J.G.; Castañer, J.; Piperacillin. Drugs Fut 1978, 3, 11, 829.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(II) |
39928 |
N(1)-ethyl-1,2-ethanediamine; N-(2-aminoethyl)-N-ethylamine
|
110-72-5 |
C4H12N2 |
详情 | 详情
|
(III) |
39929 |
1-ethyl-2,3-piperazinedione
|
59702-31-7 |
C6H10N2O2 |
详情 | 详情
|
(IV) |
24305 |
4-ethyl-2,3-dioxo-1-piperazinecarbonyl chloride
|
59703-00-3 |
C7H9ClN2O3 |
详情 | 详情
|
(V) |
31107 |
(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylethanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
69-53-4 |
C16H19N3O4S |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(B) Reduction of 3-(4-fluorobenzoyl)propionic acid (I) by means of AlCl3 in CH2Cl2 and borane/tert-butylamine complex yields alcohol (II), which is then converted into aldehyde (IV) by reaction with 4-hydroxybenzaldehyde (III) in presence of PPh3 in THF and diethyl azodicarboxylate. Treatment of (IV) with a solution of methyltriphenylphosphonium bromide in THF and a solution of n-BuLi in hexane affords styrene derivative (V), which couples with 2’-hydroxy-3’-iodoacetophenone (VI) in presence of Et3N and Pd(OAc)2 in CH3CN to provide (VII). Cyclization of (VII) by means of a first treatment with NaOEt in EtOH followed by reaction with diethyl oxalate in Et2O/EtOH yields benzopyrane derivative (VIII) which is then hydrolyzed with NaOH in THF/MeOH to give (IX). Carboxylic acid (IX) is first converted into carboxamide (X) by treatment with a saturated NH3 solution in MeOH and then into carbonitrile (XI) by means of POCl3 in DMF. Finally, treatment of (XI) with a solution of NaN3, NH4Cl and DMF leads to the formation of the desired product.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(A) |
30484 |
Methyl(triphenyl)phosphonium bromide
|
1779-49-3 |
C19H18BrP |
详情 | 详情
|
(I) |
39863 |
4-(4-fluorophenyl)-4-oxobutyric acid
|
366-77-8 |
C10H9FO3 |
详情 | 详情
|
(II) |
41474 |
4-(4-fluorophenyl)-1-butanol
|
|
C10H13FO |
详情 |
详情
|
(III) |
13433 |
4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde
|
123-08-0 |
C7H6O2 |
详情 | 详情
|
(IV) |
41475 |
4-[4-(4-fluorophenyl)butoxy]benzaldehyde
|
|
C17H17FO2 |
详情 |
详情
|
(V) |
41476 |
1-fluoro-4-[4-(4-vinylphenoxy)butyl]benzene; 4-(4-fluorophenyl)butyl 4-vinylphenyl ether
|
|
C18H19FO |
详情 |
详情
|
(VI) |
27290 |
1-(2-hydroxy-3-iodophenyl)-1-ethanone
|
|
C8H7IO2 |
详情 |
详情
|
(VII) |
41477 |
1-[3-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-2-hydroxyphenyl]-1-ethanone
|
|
C26H25FO3 |
详情 |
详情
|
(VIII) |
41478 |
ethyl 8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carboxylate
|
|
C30H27FO5 |
详情 |
详情
|
(IX) |
41479 |
8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carboxylic acid
|
|
C28H23FO5 |
详情 |
详情
|
(X) |
41480 |
8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carboxamide
|
|
C28H24FNO4 |
详情 |
详情
|
(XI) |
41481 |
8-((E)-2-[4-[4-(4-fluorophenyl)butoxy]phenyl]ethenyl)-4-oxo-4H-chromene-2-carbonitrile
|
|
C28H22FNO3 |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) The condensation of 4,5-dichloro-1,2-phenylenediamine (I) with diethyl oxalate (II) produced quinoxalinedione (III), which was brominated with PBr5 at 155 C to afford the dibromo derivative (IV). Displacement of one bromine group of (IV) with 4-(diethylamino)butylamine (V) furnished (VI). The remaining bromine of (VI) was then displaced with 2-(tributylstannyl)benzofuran (VII) to produce the title compound.
【1】
Li, J.J.; Yue, W.-S.; Trivedi, B.K.; et al.; Structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as potent, non-peptide interleukine-8-receptor antagonists. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 144.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18003 |
4,5-dichloro-1,2-benzenediamine; 4,5-Dichloro-o-phenylenediamine; 2-amino-4,5-dichlorophenylamine
|
5348-42-5 |
C6H6Cl2N2 |
详情 | 详情
|
(II) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
18007 |
6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione
|
25983-13-5 |
C8H4Cl2N2O2 |
详情 | 详情
|
(IV) |
44243 |
2,3-dibromo-6,7-dichloroquinoxaline
|
|
C8H2Br2Cl2N2 |
详情 |
详情
|
(V) |
44244 |
N-(4-aminobutyl)-N,N-diethylamine; N(1),N(1)-diethyl-1,4-butanediamine
|
|
C8H20N2 |
详情 |
详情
|
(VI) |
44245 |
N-(3-bromo-6,7-dichloro-2-quinoxalinyl)-N-[4-(diethylamino)butyl]amine; N(1)-(3-bromo-6,7-dichloro-2-quinoxalinyl)-N(4),N(4)-diethyl-1,4-butanediamine
|
|
C16H21BrCl2N4 |
详情 |
详情
|
(VII) |
44247 |
1-benzofuran-2-yl(tributyl)stannane
|
|
C20H32OSn |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(X) Claisen condensation between diethyl oxalate (X) and 2-butanone (XI) leads to the diketo ester (XII), which is subsequently cyclized with hydrazine hydrate to furnish the pyrazolecarboxylate (XIII). After alkaline hydrolysis of ester (XIII), the resultant pyrazolecarboxylic acid (XIV) is nitrated by fuming HNO3 in hot H2SO4 to provide (XV). Chlorination of acid (XV) with SOCl2, followed by treatment with ammonia in THF yields the pyrazolecarboxamide (XVI). The alkylation of pyrazole (XVI) with iodomethane and Cs2CO3 leads to a mixture of N-methylated regioisomers (XVII) and (XVIII), which are separated by crystallization, followed by column chromatography. The desired isomer (XVII) is further reduced by catalytic hydrogenation to the aminopyrazole (XIX)
【1】
Street, S.D.A.; Wood, A.; Bunnage, M.E.; Mathias, J.P. (Pfizer Inc.; Pfizer Ltd.); Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction. WO 9954333 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(XI) |
33891 |
Methyl ethyl ketone; 2-Butanone
|
78-93-3 |
C4H8O |
详情 | 详情
|
(XII) |
62099 |
ethyl 2,4-dioxohexanoate
|
|
C8H12O4 |
详情 |
详情
|
(XIII) |
62100 |
ethyl 3-ethyl-1H-pyrazole-5-carboxylate
|
|
C8H12N2O2 |
详情 |
详情
|
(XIV) |
62101 |
3-ethyl-1H-pyrazole-5-carboxylic acid
|
|
C6H8N2O2 |
详情 |
详情
|
(XV) |
62102 |
3-ethyl-4-nitro-1H-pyrazole-5-carboxylic acid
|
|
C6H7N3O4 |
详情 |
详情
|
(XVI) |
62103 |
3-ethyl-4-nitro-1H-pyrazole-5-carboxamide
|
|
C6H8N4O3 |
详情 |
详情
|
(XVII) |
62105 |
5-ethyl-1-methyl-4-nitro-1H-pyrazole-3-carboxamide
|
|
C7H10N4O3 |
详情 |
详情
|
(XVIII) |
62104 |
3-ethyl-1-methyl-4-nitro-1H-pyrazole-5-carboxamide
|
|
C7H10N4O3 |
详情 |
详情
|
(XIX) |
62106 |
4-amino-5-ethyl-1-methyl-1H-pyrazole-3-carboxamide
|
|
C7H12N4O |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(II) 2-Bromopyridine (I) is metalated by means of butyllithium and subsequently condensed with diethyl oxalate (II) to produce the keto ester adduct (III). Reaction of (III) with hot diethylaminosulfur trifluoride gives rise to the difluoro ester (IV), which is further reduced to alcohol (V) employing NaBH4 in EtOH. Treatment of (V) with triflic anhydride and 2,6-di-t-butyl-4-methylpyridine in CH2Cl2 yields the corresponding triflate (VI), which is then converted into azide (VII) by reaction with NaN3 in DMF. The pyridine ring of (VII) is oxidized by means of m-chloroperbenzoic acid to produce the N-oxide (VIII). Then, azido group reduction with PPh3 in moist THF leads to the primary amine (IX)
【1】
Selnick, H.G.; Rittle, K.E.; Barrow, J.C.; Morrissette, M.M.; Nantermet, P.G.; Staas, D. (Merck & Co., Inc.); Thrombin inhibitors. WO 0257225 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29052 |
2-Bromopyridine;α-bromopyridine;α-bromoazine |
109-04-6 |
C5H4BrN |
详情 | 详情
|
(II) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(III) |
29952 |
ethyl 2-oxo-2-(2-pyridinyl)acetate
|
|
C9H9NO3 |
详情 |
详情
|
(IV) |
63213 |
ethyl 2,2-difluoro-2-(2-pyridinyl)acetate
|
|
C9H9F2NO2 |
详情 |
详情
|
(V) |
63214 |
2,2-difluoro-2-(2-pyridinyl)-1-ethanol
|
|
C7H7F2NO |
详情 |
详情
|
(VI) |
63215 |
2,2-difluoro-2-(2-pyridinyl)ethyl trifluoromethanesulfonate
|
|
C8H6F5NO3S |
详情 |
详情
|
(VII) |
63216 |
2,2-difluoro-2-(2-pyridinyl)ethyl azide; 2-(2-azido-1,1-difluoroethyl)pyridine
|
|
C7H6F2N4 |
详情 |
详情
|
(VIII) |
63217 |
2-(2-azido-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C7H6F2N4O |
详情 |
详情
|
(IX) |
63218 |
2-(2-amino-1,1-difluoroethyl)-1-pyridiniumolate
|
|
C7H8F2N2O |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(IV) Treatment of 2-fluorobenzyl bromide (I) with hydrazine hydrate in refluxing EtOH gives 2-fluorobenzyl hydrazine (II) (1), which by cyclocondensation with the sodium salt of ethyl cyanopyruvate (III) — prepared by reaction of diethyl oxalate (IV) with acetonitrile mediated by NaOEt (2) — by means of TFA in refluxing dioxane yields the 5-aminopyrazole derivative (V). Condensation of intermediate (V) with 3-dimethylaminoacrolein (VI) in the presence of TFA in refluxing dioxane provides the pyrazolo[3,4-b]pyridine derivative (VII), which is amidated with methanolic ammonia, affording amide (VIII). Treatment of amide (VIII) with pyridine and trifluoroacetic anhydride in THF followed by methanolysis of the resulting nitrile (IX) by means of NaOMe in MeOH generates the methyl imidoate (X), which, without isolation, undergoes amination with NH4Cl in the presence of glacial acetic acid in refluxing MeOH to give the carboxamidine (XI). Coupling of amidine (XI) with phenylazomalononitrile (XII) by means of NaOMe in DMF at 110 °C affords diamine (XIII), which upon reduction with H2 over Raney-Ni in H2O/DMF at 62 °C provides triamine (XIV). Acylation of amine (XIV) with methyl chloroformate (XV) in pyridine affords carbamate (XVI), which is finally N-methylated by means of MeI and NaH in DMF (3) or LiHMDS in THF (4). Scheme 1.
【1】
Kelley, J.L., Davis, R.G., McLean, E.W., Glen, R.C., Soroko, F.E., Cooper, B.R. Synthesis and anticonvulsant activity of N-benzylpyrrolo[2,3-d]-, -pyrazolo[3,4-d]-, and -triazolo[4,5-d]pyrimidines: Imidazole ring-modified analogues of 9-(2-fluorobenzyl)-6-(methylamino)-9H-purine. J Med Chem 1995, 38(19): 3884-8. |
【2】
Von Borsche, W., Manteuffel, R. Substituted pyrazole derivatives condensed with six-membered heterocyclic rings. Justus Liebigs Ann Chem 1934, 512: 97. |
【3】
Alonso-Alija, C., Bischoff, E., Muenter, K., Feurer, A., Stahl, E., Weigand, S., Stasch, J.-P. (Bayer Healthcare AG). Carbamate-substituted pyrazolopyridines. CA 2485143, DE 10220570, EP 1506193, JP 2005531553, US 2006052397, US 7173037, WO 2003095451. |
【4】
Mittendorf, J., Weigand, S., Alonso-Alija, C. et al. Discovery of riociguat (BAY 63-2521): A potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. ChemMedChem 2009, 4(5): 853-65. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
38775 |
1-(bromomethyl)-2-fluorobenzene
|
446-48-0 |
C7H6BrF |
详情 | 详情
|
(II) |
50471 |
1-(2-fluorobenzyl)hydrazine
|
51859-98-4 |
C7H9FN2 |
详情 | 详情
|
(III) |
52079 |
sodium (Z)-1-cyano-3-ethoxy-3-oxo-1-propen-2-olate
|
627076-29-3 |
C6H6NNaO3 |
详情 | 详情
|
(IV) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(V) |
50472 |
ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate
|
256504-39-9 |
C13H14FN3O2 |
详情 | 详情
|
(VI) |
11789 |
(E)-3-(Dimethylamino)-2-propenal
|
692-32-0 |
C5H9NO |
详情 | 详情
|
(VII) |
50473 |
ethyl 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
|
256376-59-7 |
C16H14FN3O2 |
详情 | 详情
|
(VIII) |
50474 |
1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide
|
256376-62-2 |
C14H11FN4O |
详情 | 详情
|
(IX) |
50475 |
1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile
|
256376-65-5 |
C14H9FN4 |
详情 | 详情
|
(X) |
50476 |
methyl 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidoate
|
304874-06-4 |
C15H13FN4O |
详情 | 详情
|
(XI) |
50477 |
1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide
|
256376-68-8 |
C14H12FN5 |
详情 | 详情
|
(XII) |
63162 |
2-[(E)-2-phenyldiazenyl]malononitrile
|
6017-21-6 |
C9H6N4 |
详情 | 详情
|
(XIII) |
63163 |
2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(E)-2-phenyldiazenyl]-4,6-pyrimidinediamine; 6-amino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(E)-2-phenyldiazenyl]-4-pyrimidinylamine
|
428854-23-3 |
C23H18FN9 |
详情 | 详情
|
(XIV) |
63164 |
4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylamine; 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-4,5,6-pyrimidinetriamine
|
428854-24-4 |
C17H15FN8 |
详情 | 详情
|
(XV) |
16993 |
methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate |
79-22-1 |
C2H3ClO2 |
详情 | 详情
|
(XVI) |
65980 |
Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate |
625115-52-8 |
C19H17FN8O2 |
详情 | 详情
|